Stay updated on Inhaled ZYESAMI Clinical Trial
Sign up to get notified when there's something new on the Inhaled ZYESAMI Clinical Trial page.

Latest updates to the Inhaled ZYESAMI Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedThe ClinicalTrials.gov record for the inhaled ZYESAMI™ severe COVID-19 study is now displayed, with details on its design, participants, locations, and outcome measures. The record identifies the study as terminated and no longer recruiting.SummaryDifference56%

- Check14 days agoChange DetectedThe site footer now displays revision v3.8.0 instead of v3.7.2, with no change to the study record content.SummaryDifference0.2%

- Check21 days agoChange DetectedA site-wide notice announces NIH updates and explains that agencies are using “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI) during the transition.SummaryDifference1%

- Check28 days agoChange DetectedThe ClinicalTrials.gov footer now displays revision v3.7.2 instead of v3.7.1.SummaryDifference0.2%

- Check35 days agoChange DetectedThe site revision identifier changed from v3.7.0 to v3.7.1. The page continues to show a 403 error instead of study details.SummaryDifference0.2%

- Check56 days agoChange DetectedThe page displays a 403 Forbidden error, replacing the normal study details and navigation with an error screen.SummaryDifference19%

Stay in the know with updates to Inhaled ZYESAMI Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Inhaled ZYESAMI Clinical Trial page.